NYSE$PRGO

Perrigo Company · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

Perrigo's Q3 2022 financial results were reported, showcasing net sales of $1.1 billion and adjusted EPS of $0.56.

Perrigo reported strong third quarter results with net sales of $1.1 billion, a 5.5% increase year-over-year. Adjusted EPS increased by 24.4% to $0.56. The company reiterates its fiscal 2022 organic net sales growth range outlook of 9.0%-10.0% and updates its adjusted EPS range outlook to $2.00-$2.10.

  • Net sales increased by 5.5% to $1.1 billion, with organic net sales up 7.7%.
  • Adjusted gross margin increased by 210 basis points to 36.5%.
  • Adjusted operating income increased by 19.2% to $133 million.
  • Adjusted diluted EPS increased by 24.4% to $0.56.

Headline financials

Total Revenue

$1.1B

Previous: $1.04B+5.5%
EPS (adj)

$0.56

Previous: $0.45+24.4%
Adjusted Operating Income

$133M

Previous: $112M+19.2%
Adjusted Gross Margin

36.5%

No prior period
Capital Expenditures

-$70M

Previous: -$110M+36.6%
Free Cash Flow

-$119M

Previous: -$169M+29.5%
Net Income

-$49.4M

Previous: -$58.9M+16.1%
Operating Income

$33.1M

Previous: $438M-92.4%
Gross Profit

$363M

Previous: $336M+7.9%
Cash & Equivalents

$469M

Previous: $2.08B-77.4%
Total Assets

$10.7B

Previous: $10.9B-2.2%
Stock-Based Comp

$9.4M

Previous: $11.1M-15.3%

Revenue & EPS history

Perrigo · Revenue · Quarterly

$1.1B

Q3 2022+5.5%vs Q3 2021
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Revenue by segment

Perrigo · $1.1B total across 2 segments · Q3 2022

  • Consumer Self-Care Americas
    $722M+4.1%
  • Consumer Self-Care International
    $378M+8.3%

Forward guidance

The Company is updating its fiscal 2022 adjusted EPS range outlook to $2.00-$2.10 from $2.25-$2.35 and reiterates its fiscal 2022 organic net sales growth range outlook of 9.0%-10.0% versus the prior year.

Tailwinds

  • Expected accretion from the Gateway plant.
  • Expected accretion from the U.S. and Canadian rights to the Good Start® infant formula brand.
  • Reiterates fiscal 2022 organic net sales growth range outlook of 9.0%-10.0%.
  • Solid year-to-date performance in CSCI.
  • Company now expects to achieve a constant currency adjusted diluted EPS range outlook of $2.25-$2.35.

Headwinds

  • Lower sales volumes in CSCA.
  • $0.10 from the worsening impact of currency translation.
  • Now expects net sales in the full year to be unfavorably impacted by 5%-6% due to foreign currency exchange rates.
  • Now expects adjusted diluted EPS in the full year to be unfavorably impacted by approximately $0.25 due to foreign currency exchange rates.
  • Company cannot reconcile its organic net sales growth to reported net sales or its expected adjusted diluted EPS or constant currency adjusted EPS to diluted EPS under "Fiscal 2022 Outlook" without unreasonable effort.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

-1.5%

Avg return

Earnings day

-2.1%

Avg return

5 days after

-3.4%

Avg return

30 days after

48%

30 / 63 earnings

Positive

+20.2%

Q4 2024

Best reaction

-25.2%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+5.3%-5.0%-7.0%
Q4 2025-1.5%-21.0%-33.9%
Q3 2025-25.2%-29.4%-33.4%
Q1 2025+7.2%+9.4%+6.0%
Q4 2024+20.2%+22.1%+16.3%
Q3 2024+6.2%+5.4%+10.7%
Q2 2024+1.8%-1.5%+3.3%
Q1 2024-6.9%-8.1%-19.2%
Q4 2023-17.9%-18.2%+0.1%
Q3 2023+2.0%-0.2%+7.3%
Q2 2023+5.8%+7.3%-8.4%
Q1 2023+1.3%-2.2%-6.5%
Q4 2022+3.9%+6.9%-3.2%
Q3 2022-18.3%-14.9%-18.2%
Q2 2022-1.9%-1.7%-9.3%
Q1 2022+9.1%+15.6%+19.7%
Q4 2021+6.4%+4.8%+8.2%
Q3 2021-8.7%-9.8%-23.0%
Q2 2021-16.0%-16.6%-11.1%
Q1 2021+6.1%+6.4%+13.3%
Q4 2020+4.3%+1.7%+0.3%
Q3 2020-0.3%+1.5%+9.9%
Q2 2020-8.5%-6.1%-7.7%
Q1 2020-3.0%-4.4%+0.8%
Q4 2019-16.4%-12.1%-24.0%
Q3 2019-8.1%-9.3%-3.4%
Q2 2019-7.1%-5.4%-1.1%
Q1 2019+7.5%+1.7%-10.1%
Q4 2018+0.8%+4.0%-0.3%
Q3 2018-14.7%-13.0%-20.2%
Q2 2018-10.7%-11.3%-3.3%
Q1 2018-4.9%+0.4%-5.2%
Q4 2017+1.9%-6.0%-5.6%
Q3 2017+8.0%+5.9%+5.4%
Q2 2017+18.3%+17.2%+24.7%
Q1 2017+4.1%+5.0%+8.5%
Q3 2016+6.9%+6.7%-1.2%
Q2 2016-9.8%-7.2%-6.7%
Q1 2016-4.7%
Q4 2015-10.9%
Q3 2015-1.3%
Q2 2015+1.7%
Q1 2015-1.7%
Q4 2014+6.7%
Q3 2014-11.3%
Q2 2014-4.9%
Q1 2014+10.7%
Q4 2013-5.1%
Q3 2013-0.5%
Q2 2013+5.2%
Q1 2013-8.8%
Q4 2012-8.3%
Q3 2012-4.5%
Q1 2012+1.8%
Q2 2012-0.1%
Q4 2011+1.3%
Q3 2011-7.6%
Q2 2011+2.7%
Q1 2011+1.7%
Q4 2010+0.6%
Q3 2010-0.1%
Q2 2010-2.9%
Q1 2010+0.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro